
FitLife Brands clears the hard small-cap screen, but its acquisition-led growth must overcome a shrinking legacy portfolio, lower margins, and acquisition debt.
| Hard filter | FTLF reading | Screen boundary | Reproduction path |
|---|---|---|---|
| Market capitalization | $91.90M | < $10B | Finviz market cap is far below the channel limit. 1 |
| TTM revenue growth | 60.61% | > 30% | Finviz compares the latest TTM with the prior TTM. StockAnalysis reports the same rounded growth rate and TTM revenue of $101.27M. 12 |
| PEG ratio | 0.21 | < 1 | Finviz lists forward P/E of 8.05 and five-year EPS growth of 37.84%; 8.05 ÷ 37.84 = 0.213, rounded to 0.21. StockAnalysis lists PEG as unavailable, so the ratio depends on Finviz's forward-growth estimate. 13 |
| TTM operating cash flow | $10.04M | > $0 | StockAnalysis reports TTM operating cash flow of $10.04M. The latest 10-Q reports $6.119M for the first six months of 2026, versus $3.523M in the prior-year period. 34 |
| Fiscal quarter | Revenue | Revenue YoY | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|---|
| Q1 2025 | $15.94M | -3.70% | $2.02M | $0.20 | $2.33M |
| Q2 2025 | $16.13M | -4.74% | $1.75M | $0.18 | $1.20M |
| Q3 2025 | $23.49M | 46.99% | $0.92M | $0.09 | $3.67M |
| Q4 2025 | $25.91M | 72.58% | $1.64M | $0.16 | $0.24M |
| Q1 2026 | $25.33M | 58.92% | $1.72M | $0.17 | $2.48M |
| Q2 2026 | $26.55M | 64.63% | $1.95M | $0.20 | $3.64M |
| Valuation metric | FTLF | LFVN |
|---|---|---|
| Market cap | $91.90M | $79.61M |
| Trailing P/E | 15.78 | 15.89 |
| Forward P/E | 8.98 | 21.91 |
| P/S | 0.91 | 0.44 |
| EV/EBITDA | 9.24 | 7.87 |
finviz.com
stockanalysis.com
stockanalysis.com
stocktitan.net
stocktitan.net
stockanalysis.com
finance.yahoo.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.